Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-024993
Filing Date
2021-06-21
Accepted
2021-06-21 16:30:44
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3926
  Complete submission text file 0000899243-21-024993.txt   5333
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Dere Willard H (Reporting) CIK: 0001311569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 211031013

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations